Abbott Laboratories
Foreign stocks · NYSE · Healthcare · Medical supplies and devices
Makes and sells a wide range of healthcare products, including medicines, diagnostic tests, medical devices and medical nutrition, with revenue spread across the world
For every 100 dollars of sales: cost of sales 44 · operating expenses 38 · tax and other items 3 · leaving 15 as net profit
Investors in Thailand can buy ABT through 8 mutual funds open to retail investors. Most of them (8 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds ABT.
| Fund | ABT weight | How it invests | 1-year return |
|---|---|---|---|
 ONE-MEDTECHONE MEDICAL TECHNOLOGY FUND | 17.53% | Via IHI | −9.92% |
 K-GHEALTHK Global Healthcare Equity Fund | 2.96% | Via JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +16.26% |
| K-GHRMFK Global Healthcare Equity RMF | 2.96% | Via JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +16.44% |
 KFHHCARE-AKrungsri Global Healthcare Equity Hedged FX Fund | 2.89% | Via JPMorgan Funds - Global Healthcare Fund | +15.06% |
| KFHCARERMFKrungsri Global Healthcare Equity RMF | 2.88% | Via JPMorgan Funds - Global Healthcare Fund | +15.68% |
| KFHEALTH-AKrungsri Global Healthcare Equity Fund | 2.87% | Via JPMorgan Funds - Global Healthcare Fund | +23.48% |
| K-GHEALTH(UH)K Global Healthcare Equity Unhedged Fund | 2.81% | Via JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +22.56% |
 TUSHEALTH-ATISCO US Healthcare Fund | 2.75% | Via XLV | +23.08% |
Yearly average over the last 4 years · Latest annual sales 44.3B USD
For every 100 dollars of sales, about 15 dollars is left as net profit
Per year, relative to the share price · Tech stocks tend to pay little because they reinvest their profits
Now 11.6% below its 1-year high
| Item (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenue | 43.1B USD | 43.7B USD | 40.1B USD | 42.0B USD | 44.3B USD |
| Gross profit | 24.5B USD | 24.5B USD | 22.1B USD | 23.2B USD | 25.0B USD |
| Operating profit | 8.4B USD | 8.4B USD | 6.5B USD | 6.8B USD | 8.1B USD |
| Net profit | 7.1B USD | 6.9B USD | 5.7B USD | 13.4B USD | 6.5B USD |
| EPS (diluted) | 3.94 | 3.91 | 3.26 | 7.64 | 3.72 |
| Gross margin | 57.0% | 56.1% | 55.2% | 55.4% | 56.4% |
| Operating margin | 19.6% | 19.2% | 16.2% | 16.3% | 18.2% |
| Net margin | 16.4% | 15.9% | 14.3% | 31.9% | 14.7% |
| Operating cash flow | 10.5B USD | 9.6B USD | 7.3B USD | 8.6B USD | 9.6B USD |
| Free cash flow | 8.6B USD | 7.8B USD | 5.1B USD | 6.4B USD | 7.4B USD |
| Total assets | 75.2B USD | 74.4B USD | 73.2B USD | 81.4B USD | 86.7B USD |
| Total liabilities | 39.2B USD | 37.5B USD | 34.4B USD | 33.5B USD | 33.9B USD |
| Shareholders' equity | 36.0B USD | 36.9B USD | 38.8B USD | 47.9B USD | 52.8B USD |
| Period | SMA | EMA | Price vs line |
|---|---|---|---|
| 10 days | 106.26 | 107.50 | Above |
| 20 days | 104.24 | 105.36 | Above |
| 50 days | 104.05 | 104.04 | Above |
| 100 days | 102.55 | 103.24 | Above |
| 200 days | 101.54 | 105.28 | Above |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 73.47 | Down |
| MACD(12,26) | 2.02 | Up |
| ADX(14) | 24.38 | Neutral |
| ATR(14) % of price | 1.52 | Neutral |
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
KASSET3KSAM3ONEAM1TISCOASSET1| Fund | ABT weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| ONE-MEDTECH | 17.53% | IHI | −9.92% | 1.90% |
| K-GHEALTH | 2.96% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +16.26% | 1.75% |
| K-GHRMF | 2.96% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +16.44% | 1.74% |
| KFHHCARE-A | 2.89% | JPMorgan Funds - Global Healthcare Fund | +15.06% | 1.54% |
| KFHCARERMF | 2.88% | JPMorgan Funds - Global Healthcare Fund | +15.68% | 1.54% |
| KFHEALTH-A | 2.87% | JPMorgan Funds - Global Healthcare Fund | +23.48% | 1.53% |
| K-GHEALTH(UH) | 2.81% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +22.56% | 1.76% |
| TUSHEALTH-A | 2.75% | XLV | +23.08% | 1.31% |
| Master fund | Thai funds using this route | Master fund's ABT weight |
|---|---|---|
| JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | 3 | 2.96% |
| JPMorgan Funds - Global Healthcare Fund | 3 | 2.89% |
| iShares U.S. Medical Devices ETF | 1 | 17.53% |
| State Street Health Care Select Sector SPDR ETF | 1 | 2.75% |
